Marc Dejohn

Title: Innovations of Marc Dejohn in Nucleic Acid Detection

Introduction

Marc Dejohn is an accomplished inventor based in Santa Fe, NM (US). He has made significant contributions to the field of nucleic acid detection, holding a total of 3 patents. His work focuses on developing innovative solutions that enhance the efficiency and accuracy of nucleic acid identification.

Latest Patents

One of Marc Dejohn's latest patents is an integrated device for nucleic acid detection and identification. This invention features a disposable assay platform designed to detect a target nucleic acid through multiple chambers. The method for operating this assay platform allows solutions containing the target nucleic acid to move from one chamber to the next by opening a vent pocket. The resulting pressure change enables the solution to flow seamlessly to the next chamber. The platform consists of an electronic layer and one or more fluid layers that are bonded together. All heating operations can be performed using resistive heating elements integrated into the platform, while cooling operations are designed to be passive. The platform is ideally operated in a vertical orientation and can be docked to an external docking station that controls its operation.

Career Highlights

Marc Dejohn is currently associated with Mesa Biotech, Inc., where he continues to innovate in the field of biotechnology. His work has been instrumental in advancing the capabilities of nucleic acid detection technologies.

Collaborations

Some of Marc's notable coworkers include Robert B Cary and Nathan Jeremy Cobb, who contribute to the collaborative environment at Mesa Biotech, Inc.

Conclusion

Marc Dejohn's innovative work in nucleic acid detection exemplifies the impact of technology on biotechnology. His patents reflect a commitment to improving detection methods, which can lead to significant advancements in various applications.